Admission: Trellus Health plc
Trellus Health plc (Trellus) is commercialising its resilience-driven connected health solution. It will leverage expert whole-person care, data science and technology to deliver personalised and more cost-effective care for people living with chronic conditions. Trellus empowers people with chronic conditions, starting with Inflammatory Bowel Diseases (IBD), to make sustainable behaviour change that leads to better health outcomes and lower costs.
The firm will utilise the GRITT™ methodology and multidisciplinary care model, which have been scientifically validated at the Mount Sinai IBD Center to demonstrate significant improvements in patient outcomes, and over 85% reduction in emergency department visits and hospitalisations.
Crowe's team and role
Trellus Health plc (Trellus) is commercialising its resilience-driven connected health solution. It will leverage expert whole-person care, data science and technology to deliver personalised and more cost-effective care for people living with chronic conditions. Trellus empowers people with chronic conditions, starting with Inflammatory Bowel Diseases (IBD), to make sustainable behaviour change that leads to better health outcomes and lower costs.
The firm will utilise the GRITT™ methodology and multidisciplinary care model, which have been scientifically validated at the Mount Sinai IBD Center to demonstrate significant improvements in patient outcomes, and over 85% reduction in emergency department visits and hospitalisations.
Client quote
We valued the assistance of the capital markets team at Crowe in helping us with our successful IPO. They were a pleasure to work with and we appreciated their professional and efficient approach. We look forward to our journey as a public company and transforming the way complex chronic conditions are managed through our resilience-driven connected health solution that coordinates personalised clinical and behavioural care.
Monique Fayad, CEO, Trellus Health plc
